🎉 M&A multiples are live!
Check it out!

EZZ Life Science Valuation Multiples

Discover revenue and EBITDA valuation multiples for EZZ Life Science and similar public comparables like Abeona Therapeutics, Oryzon Genomics, and Genus.

EZZ Life Science Overview

About EZZ Life Science

EZZ Life Science Holdings Ltd is a genomic life science company with a mission to improve quality of life and human health. EZZ has a focus on genomic research and development to address four key human health challenges: genetic longevity, human papillomavirus (HPV), helicobacter pylori, and weight management. The company is engaged in formulation, production, marketing and sale of the EZZ branded health and wellbeing products to retailers and consumers domestically and internationally, and wholesale distribution of the EAORON branded skin care products to retailers in Australia and New Zealand.


Founded

2015

HQ

Australia
Employees

n/a

Website

ezzlife.com.au

Financials

LTM Revenue $52.5M

LTM EBITDA $7.1M

EV

$35.8M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

EZZ Life Science Financials

EZZ Life Science has a last 12-month revenue of $52.5M and a last 12-month EBITDA of $7.1M.

In the most recent fiscal year, EZZ Life Science achieved revenue of $42.0M and an EBITDA of $6.6M.

EZZ Life Science expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See EZZ Life Science valuation multiples based on analyst estimates

EZZ Life Science P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $23.5M $42.0M XXX XXX XXX
Gross Profit $4.7M $18.0M XXX XXX XXX
Gross Margin 20% 43% XXX XXX XXX
EBITDA $3.2M $6.6M XXX XXX XXX
EBITDA Margin 14% 16% XXX XXX XXX
Net Profit $0.8M $2.3M XXX XXX XXX
Net Margin 4% 5% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

EZZ Life Science Stock Performance

As of March 14, 2025, EZZ Life Science's stock price is AUD 2 (or $1).

EZZ Life Science has current market cap of AUD 75.9M (or $48.0M), and EV of AUD 56.5M (or $35.8M).

See EZZ Life Science trading valuation data

EZZ Life Science Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$35.8M $48.0M XXX XXX XXX XXX $0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

EZZ Life Science Valuation Multiples

As of March 14, 2025, EZZ Life Science has market cap of $48.0M and EV of $35.8M.

EZZ Life Science's trades at 0.7x LTM EV/Revenue multiple, and 5.0x LTM EBITDA.

Analysts estimate EZZ Life Science's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for EZZ Life Science and 10K+ public comps

EZZ Life Science Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $35.8M XXX XXX XXX
EV/Revenue 0.7x XXX XXX XXX
EV/EBITDA 5.1x XXX XXX XXX
P/E 10.2x XXX XXX XXX
P/E/Growth 0.5x XXX XXX XXX
EV/FCF 8.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get EZZ Life Science Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

EZZ Life Science Valuation Multiples

EZZ Life Science's NTM/LTM revenue growth is 16%

EZZ Life Science's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.

Over next 12 months, EZZ Life Science's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate EZZ Life Science's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for EZZ Life Science and other 10K+ public comps

EZZ Life Science Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 79% XXX XXX XXX XXX
EBITDA Margin 14% XXX XXX XXX XXX
EBITDA Growth 104% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 30% XXX XXX XXX XXX
Revenue per Employee n/a XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue 56% XXX XXX XXX XXX
G&A Expenses to Revenue 2% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 62% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

EZZ Life Science Public Comps

See public comps and valuation multiples for Genomics & Personalized Medicine and Health & Beauty comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
ToolGen XXX XXX XXX XXX XXX XXX
4basebio XXX XXX XXX XXX XXX XXX
Genus XXX XXX XXX XXX XXX XXX
Oryzon Genomics XXX XXX XXX XXX XXX XXX
Abeona Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

EZZ Life Science M&A and Investment Activity

EZZ Life Science acquired  XXX companies to date.

Last acquisition by EZZ Life Science was  XXXXXXXX, XXXXX XXXXX XXXXXX . EZZ Life Science acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by EZZ Life Science

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About EZZ Life Science

When was EZZ Life Science founded? EZZ Life Science was founded in 2015.
Where is EZZ Life Science headquartered? EZZ Life Science is headquartered in Australia.
Is EZZ Life Science publicy listed? Yes, EZZ Life Science is a public company listed on ASX.
What is the stock symbol of EZZ Life Science? EZZ Life Science trades under EZZ ticker.
When did EZZ Life Science go public? EZZ Life Science went public in 2021.
Who are competitors of EZZ Life Science? Similar companies to EZZ Life Science include e.g. ToolGen, 4basebio, Genus, Oryzon Genomics.
What is the current market cap of EZZ Life Science? EZZ Life Science's current market cap is $48.0M
What is the current revenue of EZZ Life Science? EZZ Life Science's last 12-month revenue is $52.5M.
What is the current EBITDA of EZZ Life Science? EZZ Life Science's last 12-month EBITDA is $7.1M.
What is the current EV/Revenue multiple of EZZ Life Science? Current revenue multiple of EZZ Life Science is 0.7x.
What is the current EV/EBITDA multiple of EZZ Life Science? Current EBITDA multiple of EZZ Life Science is 5.0x.
What is the current revenue growth of EZZ Life Science? EZZ Life Science revenue growth between 2023 and 2024 was 79%.
Is EZZ Life Science profitable? Yes, EZZ Life Science is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.